<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="brief-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell. Infect. Microbiol.</journal-id>
<journal-title>Frontiers in Cellular and Infection Microbiology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell. Infect. Microbiol.</abbrev-journal-title>
<issn pub-type="epub">2235-2988</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fcimb.2024.1384427</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cellular and Infection Microbiology</subject>
<subj-group>
<subject>Brief Research Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>AMR mechanisms in <italic>L. interrogans</italic> serovars: a comprehensive study</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Petakh</surname>
<given-names>Pavlo</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2170004"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Kamyshnyi</surname>
<given-names>Oleksandr</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/2058773"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>Department of Biochemistry and Pharmacology, Uzhhorod National University</institution>, <addr-line>Uzhhorod</addr-line>, <country>Ukraine</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>Department of Microbiology, Virology, and Immunology, I. Horbachevsky Ternopil National Medical University</institution>, <addr-line>Ternopil</addr-line>, <country>Ukraine</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Nayeem Ahmad, Arabian Gulf University, Bahrain</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: M. Oves, King Abdulaziz University, Saudi Arabia</p>
<p>Pankaj Dhaka, Guru Angad Dev Veterinary and Animal Sciences University, India</p>
<p>Dalia Hamza, Cairo University, Egypt</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Pavlo Petakh, <email xlink:href="mailto:pavlo.petakh@uzhnu.edu.ua">pavlo.petakh@uzhnu.edu.ua</email>; Oleksandr Kamyshnyi, <email xlink:href="mailto:kamyshnyi_om@tdmu.edu.ua">kamyshnyi_om@tdmu.edu.ua</email>
</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>11</day>
<month>04</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>14</volume>
<elocation-id>1384427</elocation-id>
<history>
<date date-type="received">
<day>09</day>
<month>02</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>26</day>
<month>03</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Petakh and Kamyshnyi</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Petakh and Kamyshnyi</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Antimicrobial resistance (AMR) is one of the global health challenges of the 21st century. Data regarding AMR mechanisms in <italic>Leptospira interrogans</italic>, the causative agents of leptospirosis, have been relatively limited. Therefore, our study aimed to identify resistance genes and explore potential resistance mechanisms specific to particular serovars. We conducted a comprehensive analysis of 98 Leptospira strains, representing 10 common serovars, using whole-genome sequencing (WGS) FASTA files. Employing the PATRIC tool from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC), we scrutinized the genomes for AMR genes. Our investigation revealed 32 genes associated with AMR, with 20 key genes consistently prevalent across most strains. Notably, we identified unique efflux pump systems in serovar Pomona, indicating distinctive resistance mechanisms in this serovar. In summary, our findings shed light on the genetic landscape of AMR in Leptospira, uncovering both common and serovar-specific resistance elements. The presence of unique efflux pump systems in serovar Pomona introduces a novel dimension to our understanding of resistance mechanisms. These insights underscore the importance of tailored intervention strategies and collaborative efforts between human and veterinary healthcare professionals, as well as environmental scientists, to address the complex dynamics of leptospirosis and its implications for antibiotic resistance.</p>
</abstract>
<kwd-group>
<kwd>
<italic>Leptospira interrogans</italic>
</kwd>
<kwd>antibiotic</kwd>
<kwd>resistance</kwd>
<kwd>leptospiral serovars</kwd>
<kwd>leptospirosis</kwd>
</kwd-group>
<counts>
<fig-count count="4"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="33"/>
<page-count count="6"/>
<word-count count="2009"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Antibiotic Resistance and New Antimicrobial drugs</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Antimicrobial resistance (AMR) presents significant challenges in addressing bacterial infections across both animal and human populations (<xref ref-type="bibr" rid="B4">Arnold et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B12">Furness et&#xa0;al., 2017</xref>). The emergence and dissemination of antimicrobial-resistant microbes over the past few decades pose a severe global health threat (<xref ref-type="bibr" rid="B28">Pulingam et&#xa0;al., 2022</xref>). AMR not only increase morbidity and mortality but also substantially impacts treatment duration and costs (<xref ref-type="bibr" rid="B19">Murray et al., 2022</xref>).</p>
<p>Although leptospirosis is endemic in tropical geographic areas, it is known as one of the most considerable global zoonotic bacterial infections, which may lead to establishing epidemics on large scales as a result of flooding and strong rainfall (<xref ref-type="bibr" rid="B13">Haake and Levett, 2015</xref>; <xref ref-type="bibr" rid="B29">Rajapakse, 2022</xref>). The zoonotic infection of leptospirosis annually may cause one million cases with a mortality rate of 6.86% (approximately 60,000 deaths) around the world (<xref ref-type="bibr" rid="B1">Adler and de la Pe&#xf1;a Moctezuma, 2010</xref>; <xref ref-type="bibr" rid="B24">Petakh and Nykyforuk, 2022</xref>; <xref ref-type="bibr" rid="B27">Petakh et&#xa0;al., 2023</xref>; <xref ref-type="bibr" rid="B21">Petakh et&#xa0;al., 2022a</xref>; <xref ref-type="bibr" rid="B22">Petakh et&#xa0;al., 2022b</xref>; <xref ref-type="bibr" rid="B23">Petakh et&#xa0;al., 2022c</xref>). The genus Leptospira comprises over 20 species based on DNA relatedness, with more than 350 serovars identified based on surface agglutinating lipopolysaccharide antigens (<xref ref-type="bibr" rid="B1">Adler and de la Pe&#xf1;a Moctezuma, 2010</xref>; <xref ref-type="bibr" rid="B11">Fouts et&#xa0;al., 2016</xref>). These species are broadly categorized into three groups. Saprophytic species like <italic>Leptospira biflexa</italic> are not associated with disease. Pathogenic species such as <italic>Leptospira interrogans</italic> and <italic>Leptospira borgpetersenii</italic> cause leptospirosis globally, ranging from mild or asymptomatic infection to severe forms resulting in multiple organ failure and death. An intermediate group, including <italic>Leptospira fainei</italic> and <italic>Leptospira licerasiae</italic>, may be associated with infection and mild disease (<xref ref-type="bibr" rid="B11">Fouts et&#xa0;al., 2016</xref>).</p>
<p>
<italic>Leptospira</italic> spp. exhibit intrinsic resistance to various antimicrobial agents, though the specific mechanisms responsible remain unidentified (<xref ref-type="bibr" rid="B2">Adler et&#xa0;al., 1986</xref>; <xref ref-type="bibr" rid="B32">Vinod Kumar et&#xa0;al., 2016</xref>; <xref ref-type="bibr" rid="B25">Petakh et&#xa0;al., 2024a</xref>; <xref ref-type="bibr" rid="B26">Petakh et&#xa0;al., 2024b</xref>). Nevertheless, resistance to sulfonamides, neomycin, actidione, polymyxin, nalidixic acid, vancomycin, and rifampicin has facilitated the development of selective media for isolating leptospires (<xref ref-type="bibr" rid="B30">Sch&#xf6;nberg, 1981</xref>).</p>
<p>In recent research, genes linked to AMR have been explored using the Comprehensive Antibiotic Resistance Database (CARD) definition (<xref ref-type="bibr" rid="B17">McArthur et&#xa0;al., 2013</xref>; <xref ref-type="bibr" rid="B16">MaChado et&#xa0;al., 2022</xref>). The CARD definition outlines different modes of AMR action:</p>
<list list-type="order">
<list-item>
<p>Antibiotic target in susceptible species: genes associated with antibiotic-sensitive wild-type bacterial components may undergo mutations, rendering them not susceptible.</p>
</list-item>
<list-item>
<p>Protein altering cell wall charge conferring antibiotic resistance: Genes involved in cell wall alteration, leading to changes in charge that confer resistance to antibiotics.</p>
</list-item>
<list-item>
<p>Gene conferring resistance via absence: deletion of specific genes or gene products results in resistance. For instance, deletion of a porin gene can block the entry of drugs into the cell.</p>
</list-item>
<list-item>
<p>Antibiotic inactivation enzyme: genes encoding enzymes that catalyze the inactivation of antibiotics, resulting in resistance: inactivation includes chemical modification, destruction, etc.</p>
</list-item>
<list-item>
<p>Efflux pump conferring antibiotic resistance: subunits of efflux proteins that pump antibiotics out of a cell to confer resistance.</p>
</list-item>
<list-item>
<p>Antibiotic target protection protein: these proteins confer antibiotic resistance by binding the antibiotic target to prevent antibiotic binding.</p>
</list-item>
<list-item>
<p>Antibiotic target modifying enzyme: enzymes that confer resistance by modifying (mutational alteration or enzymatic modification) antibiotic targets.</p>
</list-item>
<list-item>
<p>Regulator modulating expression of antibiotic resistance genes: mechanism activated by the presence of a specific antibiotic.</p>
</list-item>
</list>
<p>Current recommendations for treating human leptospirosis involve penicillin, ampicillin, ceftriaxone, or cefotaxime (<xref ref-type="bibr" rid="B1">Adler and de la Pe&#xf1;a Moctezuma, 2010</xref>; <xref ref-type="bibr" rid="B13">Haake and Levett, 2015</xref>). Alternatives, particularly for those with allergies or in non-hospital settings, include oral doxycycline or azithromycin. In veterinary settings, a penicillin-streptomycin combination is the preferred therapy for acute leptospirosis, although ampicillin, amoxicillin, tetracyclines, tulathromycin, and third-generation cephalosporins have also been utilized (<xref ref-type="bibr" rid="B9">Ellis, 2015</xref>). Tilmicosin presents an additional alternative (<xref ref-type="bibr" rid="B3">Alt et&#xa0;al., 2001</xref>).</p>
<p>The apparent absence of significant antimicrobial resistance emergence in Leptospira prompts the question of why this has not occurred (<xref ref-type="bibr" rid="B15">Liegeon et&#xa0;al., 2018</xref>). Leptospiral infections are typically monomicrobial, limiting opportunities for horizontal resistance gene acquisition. Moreover, there is no experimental evidence of foreign DNA uptake by <italic>Leptospira</italic> spp., although genomic analyses support this notion. Finally, human leptospirosis is a dead-end infection, with human-to-human transmission being extremely rare (<xref ref-type="bibr" rid="B31">Trott et&#xa0;al., 2018</xref>).</p>
<p>The study of antimicrobial resistance (AMR) mechanisms in <italic>Leptospira interrogans</italic> serovars is crucial due to the increasing global burden of leptospirosis, a zoonotic disease caused by this bacterium (<xref ref-type="bibr" rid="B5">Boss et&#xa0;al., 2019</xref>). Understanding the mechanisms that contribute to AMR in different serovars is essential for developing effective treatment strategies and controlling the spread of resistant strains. In this comprehensive study, we aim to investigate the genetic and phenotypic characteristics of AMR in <italic>L. interrogans</italic> serovars, shedding light on the factors that drive resistance and providing valuable insights for future therapeutic interventions.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<p>We conducted an analysis of FASTA files obtained from the whole-genome sequencing (WGS) of 98 strains, representing 10 common serovars in humans and animals (<xref ref-type="bibr" rid="B20">Oliveira et&#xa0;al., 2017</xref>). The distribution of strains among the serovars is as follows: Australis (n = 1); Autumnalis (n = 1); Bataviae (n = 6); Canicola (n = 11); Copenhageni (n = 30); Grippotyphosa (n = 6); Icterohaemorrhagiae (n = 11); Manilae (n = 5); Pomona (n = 16); Pyrogenes (n = 11) (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Materials</bold>
</xref>). Strains were collected during 1958 &#x2013; 2020 years.</p>
<p>We employed the PATRIC tool from the Bacterial and Viral Bioinformatics Resource Center (BV-BRC) to analyze the genomes for antimicrobial resistance (AMR) genes. The Genome Annotation Service in PATRIC uses the k-mer-based AMR gene detection method, which utilizes PATRIC&#x2019;s curated collection of representative AMR gene sequence variants and assigns to each AMR gene a functional annotation and a broad mechanism of antibiotic resistance (<xref ref-type="bibr" rid="B33">Wattam et&#xa0;al., 2017</xref>).</p>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<p>The majority of strains were isolated in Brazil (n = 17) and the United Kingdom (n = 16) (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1</bold>
</xref>). Most of the strains were obtained from humans (n = 59). In general, five main mechanisms of resistance to antibiotics were identified: gene conferring resistance via absence; protein altering cell wall charge conferring antibiotic resistance; antibiotic activation enzyme; regulator modulating expression of antibiotic resistance genes; efflux pump conferring antibiotic resistance (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2</bold>
</xref>).</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>Serovar, isolation country, host distribution, and G/C content of investigated genomes.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1384427-g001.tif"/>
</fig>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Distribution of AMR genes across all strains.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1384427-g002.tif"/>
</fig>
<p>The three predominant and widespread mechanisms were antibiotic target in susceptible species, gene conferring resistance via absence, and protein altering cell wall charge conferring antibiotic resistance, all of which were detected in all studied strains.</p>
<p>Seven genes (<italic>alr</italic>, <italic>ddl</italic>, <italic>dxr</italic>, <italic>EF-G</italic>, <italic>EF-Tu</italic>, <italic>folA</italic>, <italic>dfr</italic>) were observed in all studied strains. These genes are part of the antibiotic target in susceptible species. Antibiotic-sensitive wild-type bacterial components might undergo mutations that render them non-susceptible. All serovars had the <italic>folP</italic> gene, which encodes dihydropteroate synthase, the target enzyme of sulfonamides, except for one strain of serovar Pyrogenes (<italic>Leptospira interrogans</italic> serovar Pyrogenes str. R168). Additionally, <italic>Leptospira interrogans</italic> serovar Pyrogenes str. 200701872 did not have the <italic>gyrB</italic> gene, which encodes the B subunit of the DNA gyrase. <italic>Leptospira interrogans</italic> serovar Copenhageni str. M20 and <italic>Leptospira interrogans</italic> serovar Pyrogenes str. R168 did not have the <italic>MurA</italic> gene, a key enzyme involved in bacterial cell wall peptidoglycan synthesis and a target for the antimicrobial agent fosfomycin. <italic>Leptospira interrogans</italic> serovar Canicola strain Tande did not have the <italic>rpoB</italic> gene encoding the beta subunit of RNA polymerase (<italic>rpoB</italic>), the <italic>rpoC</italic> gene encoding DNA-directed RNA polymerase subunit beta, and the S12p gene encoding the small ribosomal protein.</p>
<p>Two mechanisms, antibiotic activation enzyme and regulator modulating expression of antibiotic resistance genes, were found among two strains of serovar Manilae. Specifically, the catalase-peroxidase enzyme KatG, encoded by the <italic>katG</italic> gene, and <italic>oxyR</italic>, the canonical orchestrator of the H<sub>2</sub>O<sub>2</sub> detoxification response, were identified. Additionally, four strains of serovar Pomona exhibited efflux pump conferring antibiotic resistance (<xref ref-type="fig" rid="f3">
<bold>Figure&#xa0;3</bold>
</xref>). Specifically, in <italic>Leptospira interrogans</italic> serovar Pomona strain EMY7780, OprM/OprM family and TolC/OpmH were identified. In <italic>Leptospira interrogans</italic> serovar Pomona strain ESR8, AcrAB-TolC, AcrAD-TolC, and TolC/OpmH were observed. Strain P5661 of <italic>Leptospira interrogans</italic> serovar Pomona showed AcrAD-TolC, AcrEF-TolC, EmrAB-TolC, EmrD, MdtABC-TolC, and MexPQ-OpmE. Lastly, in <italic>Leptospira interrogans</italic> serovar Pomona strain Pom_str68, EmrAB-OMF was found.</p>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Distribution of AMR genes across all serovars.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1384427-g003.tif"/>
</fig>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>In our study of 98 types of Leptospira bacteria, we discovered 32 genes linked to antimicrobial resistance (AMR). Out of these, 20 key genes consistently stood out in most strains. The highest number of genes was associated with a mechanism that makes antibiotics less effective in susceptible species, involving 17 different genes (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Mechanisms of AMR in <italic>L. interrogans</italic> strains.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fcimb-14-1384427-g004.tif"/>
</fig>
<p>Some crucial genes, such as <italic>alr</italic> and <italic>ddl</italic>, encode D-alanine racemase (Alr) and D-alanine:D-alanine ligase (Ddl), which are peptidoglycan biosynthetic enzymes. Feng reported that the overproduction of Alr in Mycobacterium smegmatis determines a d-Cycloserine resistance phenotype (<xref ref-type="bibr" rid="B10">Feng and Barletta, 2003</xref>).</p>
<p>Another important gene is <italic>murA</italic>, which is a key enzyme involved in bacterial cell wall peptidoglycan synthesis and is a target for the antimicrobial agent fosfomycin, a structural analog of the MurA substrate phosphoenol pyruvate (<xref ref-type="bibr" rid="B14">Kumar et&#xa0;al., 2009</xref>).</p>
<p>The <italic>dxr</italic> gene plays a significant role in building the cell membranes of bacteria. Fosmidomycin is a phosphonic antibiotic that inhibits 1-deoxy-D-xylulose 5-phosphate reductoisomerase (Dxr), the first committed step of the non-mevalonate pathway of isoprenoid biosynthesis. In Mycobacterium tuberculosis, Dxr is encoded by Rv2870c, and although the antibiotic has been shown to inhibit the recombinant enzyme, mycobacteria are intrinsically resistant to fosmidomycin at the whole-cell level (<xref ref-type="bibr" rid="B6">Brown and Parish, 2008</xref>).</p>
<p>For DNA replication and repair, DNA gyrase subunits (<italic>gyrA</italic> and <italic>gyrB</italic>) are like the repair crew for the bacterial DNA (<xref ref-type="bibr" rid="B8">Chien et&#xa0;al., 2016</xref>). Efflux pumps and mutations in <italic>gyrA</italic>, associated with fluoroquinolone resistance, have been induced <italic>in vitro</italic> in <italic>Brucella</italic> spp. strains. Think of these as defense mechanisms that bacteria develop to resist certain antibiotics.</p>
<p>An interesting discovery was made regarding certain strains of serovar Pomona. These strains possess different efflux pump systems that expel drugs, impacting bacterial resistance. This emphasizes the need to understand these variations for effective treatment. In study <italic>L. interrogans</italic> serovar Pomona isolates from swine in Brazil were found to be resistant to fluoroquinolones (<xref ref-type="bibr" rid="B18">Miraglia et&#xa0;al., 2008</xref>). We think that overexpression of efflux pumps might be the reason.</p>
<p>In a separate study by Antara Chakraborty and colleagues, 46 Leptospira isolates from rats were tested for their susceptibility to 14 antimicrobial agents (<xref ref-type="bibr" rid="B7">Chakraborty et&#xa0;al., 2010</xref>). All of the strains were found to be sensitive to ampicillin, cefotaxime, ciprofloxacin, norfloxacin, doxycycline, erythromycin, and streptomycin. In contrast, the tested isolates showed resistance to amphotericin B, 5-fluorouracil, fosfomycin, trimethoprim, sulfamethoxazole, neomycin, and vancomycin.</p>
</sec>
<sec id="s5" sec-type="conclusions">
<label>5</label>
<title>Conclusions</title>
<p>In the end, our research on AMR mechanisms in <italic>Leptospira interrogans</italic> serovars found 32 genes linked to resistance, with 20 key genes present in all strains. We believe these genes form the basis that ensures leptospira&#x2019;s resistance to certain types of antibiotics. The diverse resistance profiles observed among different <italic>Leptospira interrogans</italic> serovars underscore the complexity of antimicrobial resistance mechanisms in this bacterium.</p>
<p>The identified serovar-specific resistance mechanisms raise the prospect of tailoring therapeutic approaches based on the prevalent serovar in a specific geographical area. A nuanced understanding of the resistance patterns associated with each serovar could lead to more effective and targeted treatment strategies.</p>
<p>Efflux pump systems identified in serovar Pomona, introduce a dimension of complexity to the management of leptospirosis. The potential contribution of these systems to AMR highlights the need for future research.</p>
<p>Given its status as a zoonotic disease, understanding the interplay between human, animal, and environmental factors is crucial for comprehensive intervention strategies. The identified resistance mechanisms should prompt collaborative efforts between human and veterinary healthcare professionals, as well as environmental scientists, to address the multifaceted nature of leptospirosis and its potential impact on antibiotic resistance dynamics.</p>
</sec>
<sec id="s6" sec-type="data-availability">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>PP: Conceptualization, Investigation, Visualization, Writing &#x2013; original draft. OK: Conceptualization, Supervision, Visualization, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec id="s9" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="s10" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcimb.2024.1384427/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcimb.2024.1384427/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="Table_1.xlsx" id="SM1" mimetype="application/vnd.openxmlformats-officedocument.spreadsheetml.sheet"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adler</surname> <given-names>B.</given-names>
</name>
<name>
<surname>de la Pe&#xf1;a Moctezuma</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Leptospira and leptospirosis</article-title>. <source>Vet. Microbiol.</source> <volume>140</volume>, <fpage>287</fpage>&#x2013;<lpage>296</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.vetmic.2009.03.012</pub-id>
</citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Adler</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Faine</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Christopher</surname> <given-names>W. L.</given-names>
</name>
<name>
<surname>Chappel</surname> <given-names>R. J.</given-names>
</name>
</person-group> (<year>1986</year>). <article-title>Development of an improved selective medium for isolation of leptospires from clinical material</article-title>. <source>Vet. Microbiol.</source> <volume>12</volume>, <fpage>377</fpage>&#x2013;<lpage>381</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0378-1135(86)90087-8</pub-id>
</citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alt</surname> <given-names>D. P.</given-names>
</name>
<name>
<surname>Zuerner</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Bolin</surname> <given-names>C. A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Evaluation of antibiotics for treatment of cattle infected with Leptospira borgpetersenii serovar hardjo</article-title>. <source>J. Am. Vet. Med. Assoc.</source> <volume>219</volume>, <fpage>636</fpage>&#x2013;<lpage>639</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.2460/javma.2001.219.636</pub-id>
</citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname> <given-names>K. E.</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>N. J.</given-names>
</name>
<name>
<surname>Bennett</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>'Disperse abroad in the land': the role of wildlife in the dissemination of antimicrobial resistance</article-title>. <source>Biol. letters.</source> <volume>12</volume>, <fpage>20160137</fpage>&#x2013;<lpage>20160145</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1098/rsbl.2016.0137</pub-id>
</citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boss</surname> <given-names>J.</given-names>
</name>
<name>
<surname>Dance</surname> <given-names>D. A. B.</given-names>
</name>
<name>
<surname>Chanthongthip</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Newton</surname> <given-names>P. N.</given-names>
</name>
<name>
<surname>Wuthiekanun</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Robinson</surname> <given-names>M. T.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Antimicrobial susceptibility testing of leptospira spp. in the lao people's democratic republic using disk diffusion</article-title>. <source>Am. J. Trop. Med. Hyg.</source> <volume>100</volume>, <fpage>1073</fpage>&#x2013;<lpage>1078</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.4269/ajtmh.18-0955</pub-id>
</citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brown</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Parish</surname> <given-names>T.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Dxr is essential in Mycobacterium tuberculosis and fosmidomycin resistance is due to a lack of uptake</article-title>. <source>BMC Microbiol.</source> <volume>8</volume>, <fpage>78</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/1471-2180-8-78</pub-id>
</citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chakraborty</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Miyahara</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Villanueva</surname> <given-names>S. Y.</given-names>
</name>
<name>
<surname>Gloriani</surname> <given-names>N. G.</given-names>
</name>
<name>
<surname>Yoshida</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>
<italic>In vitro</italic> sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents</article-title>. <source>Antimicrobial. Agents chemother.</source> <volume>54</volume>, <fpage>5403</fpage>&#x2013;<lpage>5405</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.00973-10</pub-id>
</citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chien</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Chiu</surname> <given-names>W. Y.</given-names>
</name>
<name>
<surname>Chien</surname> <given-names>S. T.</given-names>
</name>
<name>
<surname>Chiang</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Yu</surname> <given-names>C. J.</given-names>
</name>
<name>
<surname>Hsueh</surname> <given-names>P. R.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Mutations in gyrA and gyrB among Fluoroquinolone- and Multidrug-Resistant Mycobacterium tuberculosis Isolates</article-title>. <source>Antimicrobial. Agents chemother.</source> <volume>60</volume>, <fpage>2090</fpage>&#x2013;<lpage>2096</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.01049-15</pub-id>
</citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ellis</surname> <given-names>W. A.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Animal leptospirosis</article-title>. <source>Curr. topics Microbiol. Immunol.</source> <volume>387</volume>, <fpage>99</fpage>&#x2013;<lpage>137</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-662-45059-8_6</pub-id>
</citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Feng</surname> <given-names>Z.</given-names>
</name>
<name>
<surname>Barletta</surname> <given-names>R. G.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Roles of Mycobacterium smegmatis D-alanine:D-alanine ligase and D-alanine racemase in the mechanisms of action of and resistance to the peptidoglycan inhibitor D-cycloserine</article-title>. <source>Antimicrobial. Agents chemother.</source> <volume>47</volume>, <fpage>283</fpage>&#x2013;<lpage>291</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.47.1.283-291.2003</pub-id>
</citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fouts</surname> <given-names>D. E.</given-names>
</name>
<name>
<surname>Matthias</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Adhikarla</surname> <given-names>H.</given-names>
</name>
<name>
<surname>Adler</surname> <given-names>B.</given-names>
</name>
<name>
<surname>Amorim-Santos</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Berg</surname> <given-names>D. E.</given-names>
</name>
<etal/>
</person-group>. (<year>2016</year>). <article-title>What makes a bacterial species pathogenic?:Comparative genomic analysis of the genus leptospira</article-title>. <source>PloS Negl. Trop. Dis.</source> <volume>10</volume>, <elocation-id>e0004403</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pntd.0004403</pub-id>
</citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Furness</surname> <given-names>L. E.</given-names>
</name>
<name>
<surname>Campbell</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Gaze</surname> <given-names>W. H.</given-names>
</name>
<name>
<surname>McDonald</surname> <given-names>R. A.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Wild small mammals as sentinels for the environmental transmission of antimicrobial resistance</article-title>. <source>Environ. Res.</source> <volume>154</volume>, <fpage>28</fpage>&#x2013;<lpage>34</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.envres.2016.12.014</pub-id>
</citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Haake</surname> <given-names>D. A.</given-names>
</name>
<name>
<surname>Levett</surname> <given-names>P. N.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Leptospirosis in humans</article-title>. <source>Leptospira leptospirosis.</source> <volume>387</volume>, <fpage>65</fpage>&#x2013;<lpage>97</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/978-3-662-45059-8_5</pub-id>
</citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kumar</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Parvathi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Hernandez</surname> <given-names>R. L.</given-names>
</name>
<name>
<surname>Cadle</surname> <given-names>K. M.</given-names>
</name>
<name>
<surname>Varela</surname> <given-names>M. F.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Identification of a novel UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) from Vibrio fischeri that confers high fosfomycin resistance in Escherichia coli</article-title>. <source>Arch. Microbiol.</source> <volume>191</volume>, <fpage>425</fpage>&#x2013;<lpage>429</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00203-009-0468-9</pub-id>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liegeon</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Delory</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Picardeau</surname> <given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antibiotic susceptibilities of livestock isolates of leptospira</article-title>. <source>Int. J. antimicrobial. agents.</source> <volume>51</volume>, <fpage>693</fpage>&#x2013;<lpage>699</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ijantimicag.2017.12.024</pub-id>
</citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>MaChado</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Barbosa</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Almeida</surname> <given-names>D.</given-names>
</name>
<name>
<surname>Andrade</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Freitas</surname> <given-names>A. C.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>A. M.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Insights into the Antimicrobial Resistance Profile of a Next Generation Probiotic Akkermansia muciniphila DSM 22959</article-title>. <source>Int. J. Environ. Res. Public Health</source> <volume>19</volume>, <fpage>9152</fpage>&#x2013;<lpage>9167</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/ijerph19159152</pub-id>
</citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McArthur</surname> <given-names>A. G.</given-names>
</name>
<name>
<surname>Waglechner</surname> <given-names>N.</given-names>
</name>
<name>
<surname>Nizam</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Yan</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Azad</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Baylay</surname> <given-names>A. J.</given-names>
</name>
<etal/>
</person-group>. (<year>2013</year>). <article-title>The comprehensive antibiotic resistance database</article-title>. <source>Antimicrobial. Agents chemother.</source> <volume>57</volume>, <fpage>3348</fpage>&#x2013;<lpage>3357</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/AAC.00419-13</pub-id>
</citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Miraglia</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Moreno</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Gomes</surname> <given-names>C. R.</given-names>
</name>
<name>
<surname>Paix&#xe3;o</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Liuson</surname> <given-names>E.</given-names>
</name>
<name>
<surname>Morais</surname> <given-names>Z. M.</given-names>
</name>
<etal/>
</person-group>. (<year>2008</year>). <article-title>Isolation and characterization of <italic>Leptospira interrogans</italic> from pigs slaughtered in S&#xe3;o Paulo State, Brazil</article-title>. <source>Braz. J. Microbiol.</source> <volume>39</volume>, <fpage>501</fpage>&#x2013;<lpage>507</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/S1517-83822008000300017</pub-id>
</citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murray</surname> <given-names>C. J. L.</given-names>
</name>
<name>
<surname>Ikuta</surname> <given-names>K. S.</given-names>
</name>
<name>
<surname>Sharara</surname> <given-names>F.</given-names>
</name>
<name>
<surname>Swetschinski</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Robles Aguilar</surname> <given-names>G.</given-names>
</name>
<name>
<surname>Gray</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis</article-title>. <source>Lancet (London England).</source> <volume>399</volume>, <fpage>629</fpage>&#x2013;<lpage>655</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0140-6736(21)02724-0</pub-id>
</citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname> <given-names>M. A. A.</given-names>
</name>
<name>
<surname>Leal</surname> <given-names>&#xc9;.</given-names>
</name>
<name>
<surname>Correia</surname> <given-names>M. A.</given-names>
</name>
<name>
<surname>Serufo Filho</surname> <given-names>J. C.</given-names>
</name>
<name>
<surname>Dias</surname> <given-names>R. S.</given-names>
</name>
<name>
<surname>Serufo</surname> <given-names>J. C.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Human leptospirosis: occurrence of serovars of Leptospira spp. in the state of Minas Gerais, Brazil, from 2008 to 2012</article-title>. <source>Braz. J. Microbiol.</source> <volume>48</volume>, <fpage>483</fpage>&#x2013;<lpage>488</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bjm.2016.12.010</pub-id>
</citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Isevych</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Griga</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kamyshnyi</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>a). <article-title>The risk factors of severe leptospirosis in the Transcarpathian region of Ukraine&#x2013;search for &#x201c;red flags&#x201d;</article-title>. <source>Arch. Balk Med. Union.</source> <volume>57</volume>, <fpage>231</fpage>&#x2013;<lpage>237</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.31688/ABMU</pub-id>
</citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Isevych</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kamyshnyi</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Oksenych</surname> <given-names>V.</given-names>
</name>
</person-group> (<year>2022</year>b). <article-title>Weil's disease-immunopathogenesis, multiple organ failure, and potential role of gut microbiota</article-title>. <source>Biomolecules</source> <volume>12</volume>, <fpage>1830</fpage>&#x2013;<lpage>1847</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/biom12121830</pub-id>
</citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Isevych</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Mohammed</surname> <given-names>I. B.</given-names>
</name>
<name>
<surname>Nykyforuk</surname> <given-names>A.</given-names>
</name>
<name>
<surname>Rostoka</surname> <given-names>L.</given-names>
</name>
</person-group> (<year>2022</year>c). <article-title>Leptospirosis: prognostic model for patient mortality in the transcarpathian region, Ukraine</article-title>. <source>Vector borne zoon. Dis. (Larchmont NY).</source> <volume>22</volume>, <fpage>584</fpage>&#x2013;<lpage>588</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/vbz.2022.0063</pub-id>
</citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Nykyforuk</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Predictors of lethality in severe leptospirosis in Transcarpathian region of Ukraine</article-title>. <source>Le infezioni medicina.</source> <volume>30</volume>, <fpage>272</fpage>&#x2013;<lpage>276</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.53854/liim-3002-13</pub-id>
</citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Oksenych</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kamyshna</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Boisak</surname> <given-names>I.</given-names>
</name>
<name>
<surname>Lyubomirskaya</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Kamyshnyi</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2024</year>a). <article-title>Exploring the complex interplay: gut microbiome, stress, and leptospirosis</article-title>. <source>Front. Microbiol.</source> <volume>15</volume>, <elocation-id>1345684</elocation-id>&#x2013;<lpage>1345700</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fmicb.2024.1345684</pub-id>
</citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Oksenych</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kamyshnyi</surname> <given-names>O.</given-names>
</name>
</person-group> (<year>2024</year>b). <article-title>Exploring Leptospira interrogans FDAARGOS_203: Insights into AMR and Anti-Phage Defense</article-title>. <source>Microorganisms</source> <volume>12</volume>, <issue>3</issue>, <fpage>546</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/microorganisms12030546</pub-id>
</citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Petakh</surname> <given-names>P.</given-names>
</name>
<name>
<surname>Rostoka</surname> <given-names>L.</given-names>
</name>
<name>
<surname>Isevych</surname> <given-names>V.</given-names>
</name>
<name>
<surname>Kamyshnyi</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>2023</year>). <article-title>Identifying risk factors and disease severity in leptospirosis: A meta-analysis of clinical predictors</article-title>. <source>Trop. doctor.</source> <volume>53</volume>, <fpage>464</fpage>&#x2013;<lpage>469</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1177/00494755231187673</pub-id>
</citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pulingam</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Parumasivam</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Gazzali</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Sulaiman</surname> <given-names>A. M.</given-names>
</name>
<name>
<surname>Chee</surname> <given-names>J. Y.</given-names>
</name>
<name>
<surname>Lakshmanan</surname> <given-names>M.</given-names>
</name>
<etal/>
</person-group>. (<year>2022</year>). <article-title>Antimicrobial resistance: Prevalence, economic burden, mechanisms of resistance and strategies to overcome</article-title>. <source>Eur. J. Pharm. Sci.</source> <volume>170</volume>, <fpage>106103</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ejps.2021.106103</pub-id>
</citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rajapakse</surname> <given-names>S.</given-names>
</name>
</person-group> (<year>2022</year>). <article-title>Leptospirosis: clinical aspects</article-title>. <source>Clin. Med.</source> <volume>22</volume>, <fpage>14</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.7861/clinmed.2021-0784</pub-id>
</citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sch&#xf6;nberg</surname> <given-names>A.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>Studies on the effect of antibiotic substances on leptospires and their cultivation from material with a high bacterial count</article-title>. <source>Zentralblatt fur Bakteriologie 1 Abt Originale A: Medizinische Mikrobiologie Infektionskrankheiten und Parasitologie.</source> <volume>249</volume>, <fpage>400</fpage>&#x2013;<lpage>406</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0174-3031(81)80096-0</pub-id>
</citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Trott</surname> <given-names>D. J.</given-names>
</name>
<name>
<surname>Abraham</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Adler</surname> <given-names>B.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Antimicrobial resistance in leptospira, brucella, and other rarely investigated veterinary and zoonotic pathogens</article-title>. <source>Microbiol. spect.</source> <volume>6</volume>. doi:&#xa0;<pub-id pub-id-type="doi">10.1128/microbiolspec.ARBA-0029-2017</pub-id>
</citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vinod Kumar</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Lall</surname> <given-names>C.</given-names>
</name>
<name>
<surname>Raj</surname> <given-names>R. V.</given-names>
</name>
<name>
<surname>Vedhagiri</surname> <given-names>K.</given-names>
</name>
<name>
<surname>Sunish</surname> <given-names>I. P.</given-names>
</name>
<name>
<surname>Vijayachari</surname> <given-names>P.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>
<italic>In vitro</italic> antimicrobial susceptibility of pathogenic leptospira biofilm</article-title>. <source>Microbial. Drug resist. (Larchmont NY).</source> <volume>22</volume>, <fpage>511</fpage>&#x2013;<lpage>514</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1089/mdr.2015.0284</pub-id>
</citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wattam</surname> <given-names>A. R.</given-names>
</name>
<name>
<surname>Davis</surname> <given-names>J. J.</given-names>
</name>
<name>
<surname>Assaf</surname> <given-names>R.</given-names>
</name>
<name>
<surname>Boisvert</surname> <given-names>S.</given-names>
</name>
<name>
<surname>Brettin</surname> <given-names>T.</given-names>
</name>
<name>
<surname>Bun</surname> <given-names>C.</given-names>
</name>
<etal/>
</person-group>. (<year>2017</year>). <article-title>Improvements to PATRIC, the all-bacterial bioinformatics database and analysis resource center</article-title>. <source>Nucleic Acids Res.</source> <volume>45</volume>, <fpage>D535</fpage>&#x2013;<lpage>Dd42</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1093/nar/gkw1017</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>